Medical / Pharmaceutical Trend
Big Pharma Joins the Obesity Drug Party
Obesity treatment drug “Welcome to the party.”On the 13th (local time) at the JP Morgan Healthcare Conference (JPMHC) in San Francisco, USA, David Ricks, chief executive officer (CEO) of Eli Lilly, the developer of the obesity treatment drug “Mounjaro,” addressed competitors entering the obesity dru
2026.01.14